1. Home
  2. FNGR vs COCH Comparison

FNGR vs COCH Comparison

Compare FNGR & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FingerMotion Inc.

FNGR

FingerMotion Inc.

HOLD

Current Price

$0.47

Market Cap

50.2M

Sector

Technology

ML Signal

HOLD

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.66

Market Cap

49.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNGR
COCH
Founded
2016
1995
Country
Singapore
United States
Employees
N/A
47
Industry
Computer Software: Prepackaged Software
Blank Checks
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
50.2M
49.7M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
FNGR
COCH
Price
$0.47
$0.66
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
1.4M
106.4K
Earning Date
05-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,132,261.00
N/A
Revenue This Year
N/A
$1.58
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$0.36
52 Week High
$2.35
$1.89

Technical Indicators

Market Signals
Indicator
FNGR
COCH
Relative Strength Index (RSI) 32.51 49.65
Support Level N/A $0.64
Resistance Level $1.12 $0.73
Average True Range (ATR) 0.11 0.03
MACD -0.02 -0.00
Stochastic Oscillator 7.34 55.67

Price Performance

Historical Comparison
FNGR
COCH

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company's business line includes Telecommunications Products and Services, Value Added Products and Services, Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: